Somewhat Favorable Media Coverage Somewhat Unlikely to Impact Clorox Company (The) (CLX) Stock Price

Headlines about Clorox Company (The) (NYSE:CLX) have been trending somewhat positive on Monday, Accern Sentiment Analysis reports. Accern scores the sentiment of press coverage by reviewing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Clorox Company (The) earned a news impact score of 0.17 on Accern’s scale. Accern also gave news headlines about the company an impact score of 47.3953845676136 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the headlines that may have impacted Accern’s analysis:

Several research analysts recently weighed in on the company. Jefferies Group LLC restated a “hold” rating and set a $137.00 target price (up from $136.00) on shares of Clorox Company (The) in a research note on Wednesday, August 9th. Royal Bank Of Canada reaffirmed a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Zacks Investment Research cut Clorox Company (The) from a “buy” rating to a “hold” rating in a research report on Monday, July 31st. BidaskClub cut Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research report on Monday, July 24th. Finally, BMO Capital Markets reaffirmed an “outperform” rating on shares of Clorox Company (The) in a research report on Tuesday, September 12th. Two investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have issued a buy rating to the company’s stock. Clorox Company (The) has an average rating of “Hold” and an average price target of $128.72.

Clorox Company (NYSE:CLX) traded down $1.03 during midday trading on Monday, reaching $133.51. The company had a trading volume of 633,100 shares, compared to its average volume of 815,117. The firm has a market cap of $17,380.00, a PE ratio of 24.06, a price-to-earnings-growth ratio of 3.64 and a beta of 0.39. Clorox Company has a 12 month low of $112.28 and a 12 month high of $141.76. The company has a quick ratio of 0.77, a current ratio of 1.10 and a debt-to-equity ratio of 3.02.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Wednesday, November 1st. The company reported $1.46 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.05. The company had revenue of $1.50 billion during the quarter, compared to analysts’ expectations of $1.48 billion. Clorox Company (The) had a return on equity of 161.59% and a net margin of 11.84%. Clorox Company (The)’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.36 EPS. equities analysts anticipate that Clorox Company will post 5.58 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, February 9th. Investors of record on Wednesday, January 24th will be issued a $0.84 dividend. The ex-dividend date of this dividend is Tuesday, January 23rd. This represents a $3.36 dividend on an annualized basis and a yield of 2.52%. Clorox Company (The)’s payout ratio is 61.65%.

In related news, SVP Matthew T. Laszlo sold 20,051 shares of the company’s stock in a transaction dated Wednesday, November 8th. The stock was sold at an average price of $130.46, for a total value of $2,615,853.46. Following the completion of the transaction, the senior vice president now owns 10,896 shares of the company’s stock, valued at approximately $1,421,492.16. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction dated Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the transaction, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The disclosure for this sale can be found here. Insiders sold a total of 41,293 shares of company stock valued at $5,560,303 in the last ninety days. 1.00% of the stock is currently owned by insiders.

WARNING: This article was posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this article on another website, it was copied illegally and reposted in violation of U.S. & international trademark and copyright legislation. The original version of this article can be accessed at https://sportsperspectives.com/2017/11/20/somewhat-favorable-media-coverage-somewhat-unlikely-to-impact-clorox-company-the-clx-stock-price.html.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Insider Buying and Selling by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply